Analyst Report: EXPN.L
1. EXECUTIVE SUMMARY
Experian rose 10.76% over the week to a close of 2,986.00p on Wednesday 21 October 2026, from 2,696.00p on 14 October. Most of the gain came in three sessions. The first was Thursday 15 October (+5.90%), when the credit bureaus rallied together after TransUnion jumped just over 10% (Seeking Alpha). The other two were Tuesday 20 October (+2.72%) and Wednesday 21 October (+2.65%), after Equifax reported third-quarter earnings above forecast, which Kalkine Media described as a read-across that eased AI-disruption worries. The brief found no Experian-specific news behind any of these sessions, so the move reflects sector sentiment. Volume on the latest session was 0.61x the 50-session average, so the advance came on thin trading. The next test is first-half FY27 results on 18 November.
2. THE CATALYST
The move built over three sessions.
| Session | Close | Change | Driver per brief |
|---|---|---|---|
| Thu 15 Oct | 2,855.00p | +5.90% | Sector rally led by TransUnion (Seeking Alpha) |
| Tue 20 Oct | 2,909.00p | +2.72% | Equifax Q3 beat read-across (Kalkine Media) |
| Wed 21 Oct | 2,986.00p | +2.65% | Continuation; no separate source |
On 15 October, Seeking Alpha reported that TransUnion surged just over 10%, with Equifax up more than 7% and Experian up nearly 7%. That article's figure for Experian differs from the +5.90% close-to-close change in the site's data, and no source explains the gap. Seeking Alpha cited TransUnion-specific drivers (a recovery after a sharp drop, sector moves and a Bankrate partnership) and named no single trigger for Experian. GuruFocus framed the rebound as following a weak September for TransUnion.
On 20 October, Kalkine Media reported that Equifax's third-quarter earnings beat forecasts and that Experian rose in London as a result, with AI-disruption worries for credit data names easing. Barron's, via Yahoo Finance, headlined Equifax as the S&P 500's best performer that day and linked it to VantageScore, but the research assistant read only the summary. Only Kalkine supports attributing the 20 and 21 October gains to Equifax, and the brief found no Experian-specific news for the 21st.
Other items in the window carry no confirmed link to the price. Experian Health acquired eInsights on 20 October (terms undisclosed, per Yahoo Finance). VantageScore launched a mortgage credit-score simulator API covering all three bureaus on 16 October (Business Wire), and no source ties it to Experian's move.
3. COMPANY PROFILE
Experian is a data and technology company in the Industrials sector (Consulting Services), operating through Business-to-Business and Consumer Services segments across North America, Latin America, the UK and Ireland, Europe, the Middle East, Africa and Asia Pacific. It sells data, software and AI-enabled analytics for decisioning, risk management and fraud prevention, plus credit information and identity protection for consumers. The closest competitors named in the sources are Equifax and TransUnion. Market capitalisation is £27.02bn.
Recent results from the brief:
- FY26 (May 2026): record annual results, an 11% dividend increase and a new $1bn buyback running to June 2027. Shares fell on organic growth guidance below City expectations (Proactive Investors; Kalkine Media).
- Q1 FY27 (quarter to 30 June): revenue grew 10% and organic growth was 7%. North America slowed to 7% organic from 10%, and full-year guidance was unchanged (Proactive Investors, mid-July, exact date unconfirmed).
- Product activity: Cashflow Data Bureau launched on 7 October, with a claimed predictive lift of up to 40% (Ad-hoc News, citing Simply Wall St).
- Buyback: Experian reported repurchasing 466,687 shares on 8 October (Investegate via Ad-hoc News).
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? Nothing in the brief changes Experian's earnings outlook during the week. The gains follow peer news and a shift in sentiment about AI disruption, which Kalkine calls the main overhang on the shares this year. Equifax's beat is evidence that credit data demand holds up, and it informs Experian's read-across without being Experian's own result. The shares remain 10.37% lower year to date and well below the 52-week high of 3,706.31p set on 28 October 2025.
Analyst stance. RBC Capital kept Outperform on 16 October but cut its target from 4,000p to 3,300p, citing higher rates, softer consumer lending and regulatory risk around mortgage credit-score changes (Ad-hoc News; TipRanks). The note framed the cut as a recalibration ahead of bureau third-quarter results. The 3,300p target sits 10.5% above the latest close. TipRanks lists a consensus target of £3,604.20 with no date, so treat it with caution.
Comparable episodes. Sentiment has swung hard on single events this year. In mid-July the shares fell more than 6% and led FTSE 100 fallers after North America growth slowed in Q1 (Proactive Investors, date inferred from page age). On May results day they fell despite record results and a buyback, on weaker guidance and AI concerns (Kalkine Media; Proactive Investors). TransUnion's rebound from a September pullback is the nearest sector analogue to the 15 October move (GuruFocus).
Peer read-across. The site's peer set consists of support-services names and excludes the credit bureaus: ITRK.L +0.08%, BNZL.L -1.22%, RTO.L +2.68%, DCC.L +0.16% and CPG.L +5.90%. The FTSE 100 rose 0.26% over the same period, so Experian outperformed the index by a wide margin. Equifax and TransUnion are the relevant comparators.
Bull case. The sector rebound and Equifax's beat ease the AI-disruption concern. Valuation at a forward P/E of 18.2 sits well below the trailing 26.1, implying earnings growth in analyst forecasts. The $1bn buyback runs to June 2027, and RBC retains an Outperform rating.
Bear case. The rally rests on peer news and carries no Experian-specific catalyst. A possible move from tri-merge to bi-merge mortgage credit reporting was raised as a risk (Seeking Alpha), with no decision date found. North America growth has slowed, and RBC flagged softer consumer lending and higher rates.
5. TECHNICAL SNAPSHOT
The close of 2,986.00p is the highest in the ten-session table and sits above both the 50-day average (2,770.80p) and the 200-day average (2,726.41p), having cleared both after the 15 October jump. The price is 19.4% below the 52-week high of 3,706.31p and 35.6% above the 52-week low of 2,202.69p. The latest session's volume of 1,546,241 was 0.61x the 50-session average. The heaviest volumes in the table, 3,550,502 on 8 October and 3,668,418 on 9 October, came before the rally, so the advance has not drawn the volume seen earlier. The latest close is the highest in the table, so there is no resistance level to name from the closes. The nearest support is the 2,909.00p close of 20 October.
6. RISK FACTORS
- Sector dependence. The rise rests on peer results and sentiment. A reversal in Equifax or TransUnion would carry over to Experian.
- AI disruption. Kalkine names it as the main overhang this year, and the recent easing has no Experian-specific confirmation.
- Regulation. A possible change from tri-merge to bi-merge mortgage reporting would affect bureau revenue, with no decision date found (Seeking Alpha). RBC also cited regulatory risk around mortgage credit-score changes.
- Macro. Higher rates and softer consumer lending were cited by RBC.
- Growth. North America organic growth slowed to 7% from 10% in Q1 (Proactive Investors).
Dated catalysts:
- 18 November 2026: first-half FY27 results, the next scheduled test of growth.
- Bureau third-quarter results: RBC referred to them, but the brief found no dates for Equifax or TransUnion beyond Equifax's report on 20 October.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). The shares trade above both moving averages after a sector-led rally on lighter volume. Trading depends on TransUnion and Equifax sentiment, as no Experian-specific news is scheduled before results. A hold above 2,909.00p would keep the rally intact, while a fall through that close would put the 2,832.00p close of 19 October in view (inference from the daily closes).
Medium term (1-3 months). The 18 November results are the main event. North America organic growth and any change to full-year guidance will set the direction, since the May and July reactions showed the shares react sharply to growth guidance. RBC's 3,300p target gives one reference point for the upside.
Long-term thesis. Nothing in the brief changes it. Experian remains a large credit data and analytics business with a buyback in progress, and the debate centres on AI disruption, mortgage scoring regulation and North American growth. This is analysis only and not personal financial advice.